CervoMed Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CervoMed Inc. (CRVO) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 20.52 thousand shares for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-19.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2019-03-19
- CervoMed Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-06-30 was 3.04M shares.
- CervoMed Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 20.52K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | 20.52K shares 10-K · filed 2019-03-19 | 307.68K shares 10-K · filed 2018-04-02 | |||
| 2017-09-30 | 816.58K shares 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | 3.04M shares 10-Q · filed 2018-08-10 | 1.76M shares 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |